Response Biomedical Q3 FY14: net loss $1.1M; diluted EPS −$0.14

Key figures from this report

These are the numbers Response Biomedical reported for Q3 FY14, the quarter ended Sep 30, 2014, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

1. Net income−$1.1MNo year-earlier figure tagged10-Q income statement, on EDGAR
2. Diluted EPS−$0.14No year-earlier figure tagged10-Q income statement, on EDGAR
3. Cash and cash equivalents$1.7MNo year-earlier figure tagged10-Q balance sheet, on EDGAR
4. Cash from operations−$750KNo year-earlier figure tagged10-Q cash flow statement, on EDGAR; the filing reports year-to-date cash flows; this quarter is the year-to-date total less the earlier quarters